Divergence is an outstanding strategic R&D partner for established and emerging firms with market channels in agriculture and infectious disease. Divergence's strength is outstanding science for discovery and early-stage product development. Third party relationships are important for our success to move products through later-stage development and into commercialization.

Divergence is committed to advancing its candidates of anti-parasitic compounds and plant traits through relationships with crop protection, animal health, and pharmaceutical companies, as well as other research entities. Our multiple research platforms (RNAi, STEM™, and Harvest™), extensive patent estate, and team of over twenty scientists offer compelling opportunities for partnerships. Divergence currently has major ongoing research collaborations in plant biotechnology and animal health, both of which have reached milestones and been extended. Divergence has also executed two additional licensing relationships.